4.6 Article

PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Pleiotropic effects of thiazolidinediones: Taking a look beyond antidiabetic activity

S Giannini et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)

Article Endocrinology & Metabolism

Combination therapy with PPARγ and PPARα agonists increases glucose-stimulated insulin secretion in db/db mice

K Yajima et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)

Review Biotechnology & Applied Microbiology

Peroxisome proliferator-activated receptors: insight into multiple cellular functions

P Escher et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2000)